1
TITLE: The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence
AUTHORS: Luis, Mariana; Boers, Maarten; Saag, Ken; Buttgereit, Frank; da Silva, Jose A. P.;
PUBLISHED: 2022, SOURCE: CURRENT OPINION IN RHEUMATOLOGY, VOLUME: 34, ISSUE: 3
INDEXED IN: WOS
2
TITLE: The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence
AUTHORS: Luís, M; Boers, M; Saag, K; Buttgereit, F; da Silva, JAP;
PUBLISHED: 2022, SOURCE: Current opinion in rheumatology, VOLUME: 34, ISSUE: 3
INDEXED IN: Scopus
3
TITLE: Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis
AUTHORS: Santiago, T; Jacobs, JW; Saag, KG; Buttgereit, F; Pereira da Silva, JAP;
PUBLISHED: 2015, SOURCE: ACTA REUMATOLOGICA PORTUGUESA, VOLUME: 40, ISSUE: 1
INDEXED IN: Scopus WOS
4
TITLE: Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
AUTHORS: van der Goes, MC; Jacobs, JWG; Boers, M; Andrews, T; Blom Bakkers, MAM; Buttgereit, F; Caeyers, N; Choy, EH; Cutolo, M; Da Silva, JAP; Guillevin, L; Holland, M; Kirwan, JR; Rovensky, J; Saag, KG; Severijns, G; Webber, S; Westhovens, R; Bijlsma, JWJ;
PUBLISHED: 2010, SOURCE: ANNALS OF THE RHEUMATIC DISEASES, VOLUME: 69, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
5
TITLE: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
AUTHORS: Hoes, JN; Jacobs, JWG; Boers, M; Boumpas, D; Buttgereit, F; Caeyers, N; Choy, EH; Cutolo, M; Da Silva, JAP; Esselens, G; Guillevin, L; Hafstrom, I; Kirwan, JR; Rovensky, J; Russell, A; Saag, KG; Svensson, B; Westhovens, R; Zeidler, H; Bijlsma, JWJ;
PUBLISHED: 2007, SOURCE: ANNALS OF THE RHEUMATIC DISEASES, VOLUME: 66, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef
6
TITLE: Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
AUTHORS: Da Silva, JAP; Jacobs, JWG; Kirwan, JR; Boers, M; Saag, KG; Ines, LBS; de Koning, EJP; Buttgereit, F; Cutolo, M; Capell, H; Rau, R; Bijlsma, JWJ;
PUBLISHED: 2006, SOURCE: ANNALS OF THE RHEUMATIC DISEASES, VOLUME: 65, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
7
TITLE: Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids - A randomized, double-blind, placebo-controlled extension trial  Full Text
AUTHORS: Adachi, JD; Saag, KG; Delmas, PD; Liberman, UA; Emkey, RD; Seeman, E; Lane, NE; Kaufman, JM; Poubelle, PEE; Hawkins, F; Correa Rotter, R; Menkes, CJ; Rodriguez Portales, JA; Schnitzer, TJ; Block, JA; Wing, J; McIlwain, HH; Westhovens, R; Brown, J; Melo Gomes, JA; Gruber, BL; Yanover, MJ; Leite, MOR; Siminoski, KG; Nevitt, MC; Sharp, JT; Malice, MP; Dumortier, T; Czachur, M; Carofano, W; Daifotis, A; ...More
PUBLISHED: 2001, SOURCE: ARTHRITIS AND RHEUMATISM, VOLUME: 44, ISSUE: 1
INDEXED IN: WOS CrossRef
8
TITLE: Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
AUTHORS: Saag, KG; Emkey, R; Schnitzer, TJ; Brown, JP; Hawkins, F; Goemaere, S; Thamsborg, G; Liberman, UA; Delmas, PD; Malice, MP; Czachur, M; Daifotis, AG; Lane, N; Correa Rotter, R; Yanover, M; Westhovens, R; Epstein, S; Adachi, JD; Poubelle, P; Melo Gomes, J; Rodriguez Portales, JA; ...More
PUBLISHED: 1998, SOURCE: New England Journal of Medicine, VOLUME: 339, ISSUE: 5
INDEXED IN: Scopus CrossRef